Canada Goose Holdings Inc. (TSE:GOOS – Get Free Report)’s share price reached a new 52-week low during trading on Wednesday . The company traded as low as C$12.80 and last traded at C$13.06, with a volume of 19415 shares. The stock had previously closed at C$12.83.
Wall Street Analysts Forecast Growth
Separately, Wells Fargo & Company cut their price objective on Canada Goose from C$22.00 to C$19.00 and set an “overweight” rating on the stock in a research note on Friday, February 6th. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of C$22.00.
View Our Latest Stock Analysis on Canada Goose
Canada Goose Stock Performance
Canada Goose (TSE:GOOS – Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported C$0.37 earnings per share for the quarter. The business had revenue of C$453.30 million during the quarter. Canada Goose had a return on equity of 4.29% and a net margin of 1.47%. On average, research analysts predict that Canada Goose Holdings Inc. will post 1.6222664 EPS for the current year.
Canada Goose Company Profile
Canada Goose Holdings Inc is a Canada based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in the luxury shopping locations. The Wholesale segment comprises sales made to a mix of functional and fashionable retailers, including major luxury department stores, outdoor specialty stores, and individual shops, and to international distributors.
Featured Stories
- Five stocks we like better than Canada Goose
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
- The Great AI Rotation: Cashing In on Data
- Mirum Pharma: A Rare Disease Growth Story to Watch
- The Great Cloud Divide: How AI Is Reshuffling the Software Deck
Receive News & Ratings for Canada Goose Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canada Goose and related companies with MarketBeat.com's FREE daily email newsletter.
